Techniker Krankenkasse Tender

Contract notice: open house discount contracts 2021-16 The health insurers pursue the goal of entering into discount agreements with all suitable pharmaceutical companies in accordance with section 130a para. 8 sgb v to close on the active ingredient sorafenib. the contract is concluded as part of the open-house procedure: individual negotiations about the content of the contract are not conducted, uniform conditions apply. the health insurances do not guarantee individual contractual partners any exclusivity. the contract term is a maximum of 24 months, beginning on february 1, 2022 at the earliest. the contract ends on january 31, 2024 at the latest, regardless of the date of the conclusion of the contract. it is possible to join this open-house procedure at any time during the term of the contract. all further information can be found in the participation and contract documents.The non-exclusive discount contracts concluded in the open-house procedure of the health insurers serve to bridge the period between the patent expiry of active ingredients, active ingredient combinations or dosage forms, active strengths and the entry into force of exclusive discount contracts according to § 130a para. 8 sgb v. it is possible to join this open-house procedure at any time during the term of the contract. a contract is concluded with all pharmaceutical companies who meet the requirements of the self-declaration of approval and reliability contained in the procedural documents and who confirm this in text form in accordance with section 126b of the german civil code. this announcement does not concern the award of a public contract within the meaning of the procurement law guideline (2014/24 / ec) or the antitrust procurement law. in the interest of the broadest possible information for interested pharmaceutical companies, this announcement is made in the supplement to the official gazette of the european union. the process designation "open procedure" (section iv.1.1)) used in the context of this announcement text and the specification of the award criteria (section ii.2.5)) are owed to the specifications of the announcement form and have no further meaning. this, as well as the use of the "ted" medium, is not associated with any submission to public procurement regulations, the validity of which is not prescribed by law or procurement regulations.